查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1417201

青光眼市場報告：2030 年趨勢、預測與競爭分析

Glaucoma Market Report: Trends, Forecast and Competitive Analysis to 2030
出版日期: | 出版商: Lucintel | 英文 150 - page report | 商品交期: 3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

青光眼趨勢和預測

預計到 2030 年，全球青光眼市場將達到 120.4 億美元，2024 年至 2030 年年複合成長率為 7.0%。該市場的主要促進因素是青光眼盛行率的增加、人們對青光眼的認知不斷提高以及眼科領域對新型治療策略的需求不斷成長。全球青光眼市場的未來前景廣闊，醫院藥局、零售藥局和線上藥局市場充滿機會。

青光眼市場洞察

Lucintel 預測，由於睡眠呼吸中止症、血管疾病和視力模糊等與老齡化相關的眼科疾病率不斷上升，開放性青光眼在預測期內將出現最高成長。

由於診斷、治療和新藥管理方面的進步，預計亞太地區在預測期內將出現最高成長

常問問題

Q.1 青光眼的市場規模有多大？

A1. 到2030年，全球青光眼市場預計將達到120.4億美元。

Q.2 青光眼市場的成長預測是多少？

A2. 2024年至2030年，全球青光眼市場預計將以7.0%的年複合成長率成長。

Q.3 影響青光眼市場成長的關鍵因素有哪些：

A3. 該市場的主要驅動力是青光眼盛行率的增加、對青光眼的認知不斷提高以及眼科領域對新型治療策略的需求不斷成長。

Q4.市場的主要細分市場是：

A4. 青光眼市場前景廣闊，醫院藥局、零售藥局、網路藥局市場充滿機會。

Q5.市場的主要企業是：

A5.主要的青光眼公司如下。

  • Pfizer
  • Santen Pharmaceutical
  • Novartis
  • Alcon
  • Akron Operating Company
  • Thea Pharma
  • AbbVie
  • Bausch+Lomb Corporation
  • Teva Pharmaceuticals Industries
  • 0

Q6.未來最大的細分市場是什麼？

A6.Lucintel 預測，由於睡眠呼吸中止症、血管疾病和視力模糊等與老齡化相關的眼科疾病盛行率不斷上升，開放性青光眼將在預測期內出現最高成長。Masu。

Q7. 未來五年預計哪些地區的市場成長最大？

A7. 由於診斷、治療和新藥交付方面的進步，預計亞太地區將在預測期內實現最高成長。

Q8. 可以客製化報告嗎？

A8. 是的，Lucintel 提供 10% 的客製化服務，無需額外付費。

目錄

第1章執行摘要

第2章全球青光眼市場：市場動態

  • 簡介、背景、分類
  • 供應鏈
  • 產業促進因素與挑戰

第3章 2018-2030年市場趨勢及預測分析

  • 宏觀經濟趨勢（2018-2023）與預測（2024-2030）
  • 全球青光眼市場趨勢（2018-2023）與預測（2024-2030）
  • 按疾病類型分類的全球青光眼市場
    • 開放性青光眼
    • 隅角閉鎖性青光眼
    • 其他
  • 按藥物類別分類的全球青光眼市場
    • Gland類似物
    • BETA受體阻斷劑
    • 腎上腺素能促效劑
    • 碳酸酐酶抑制劑
    • 其他
  • 按分銷通路分類的全球青光眼市場
    • 醫院藥房
    • 零售藥房
    • 網路藥房

第4章 2018-2030年區域市場趨勢及預測分析

  • 全球青光眼市場按地區分類
  • 北美青光眼市場
  • 歐洲青光眼市場
  • 亞太青光眼市場
  • 其他地區青光眼市場

第5章 競爭分析

  • 產品系列分析
  • 營運整合
  • 波特五力分析

第6章 成長機會與策略分析

  • 成長機會分析
    • 按疾病類型分類的全球青光眼市場成長機會
    • 按藥物類別分類的全球青光眼市場成長機會
    • 按分銷管道分類的全球青光眼市場成長機會
    • 按地區分類的全球青光眼市場成長機會
  • 全球青光眼市場新趨勢
  • 戰略分析
    • 新產品開發
    • 擴大全球青光眼市場的產能
    • 全球青光眼市場的合併、收購和合資企業
    • 認證和許可

第7章主要企業概況

  • Pfizer
  • Santen Pharmaceutical
  • Novartis
  • Alcon
  • Akron Operating Company
  • Thea Pharma
  • AbbVie
  • Bausch+Lomb Corporation
  • Teva Pharmaceuticals Industries
簡介目錄

Glaucoma Trends and Forecast

The future of the global glaucoma market looks promising with opportunities in the hospital pharmacy, retail pharmacy, and online pharmacy markets. The global glaucoma market is expected to reach an estimated $12.04 billion by 2030 with a CAGR of 7.0% from 2024 to 2030. The major drivers for this market are increasing glaucoma incidence rates and increasing glaucoma awareness and growing need in the field of ophthalmology for novel treatment strategies.

A more than 150-page report is developed to help in your business decisions.

Glaucoma by Segment

The study includes a forecast for the global glaucoma by disease type, drug class, distribution channel, and region.

Glaucoma Market by Disease Type [Shipment Analysis by Value from 2018 to 2030]:

  • Open Angle Glaucoma
  • Angle Closure Glaucoma
  • Others

Glaucoma Market by Drug Class [Shipment Analysis by Value from 2018 to 2030]:

  • Prostaglandins Analogs
  • Beta-blockers
  • Adrenergic Agonists
  • Carbonic Anhydrase Inhibitors
  • Others

Glaucoma Market by Distribution Channel [Shipment Analysis by Value from 2018 to 2030]:

  • Hospital Pharmacy
  • Retail Pharmacy
  • Online Pharmacy

Glaucoma Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Glaucoma Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies glaucoma companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the glaucoma companies profiled in this report include-

  • Pfizer
  • Santen Pharmaceutical
  • Novartis
  • Alcon
  • Akron Operating Company
  • Thea Pharma
  • Abbvie
  • Bausch + Lomb Corporation
  • Teva Pharmaceuticals Industries

Glaucoma Market Insights

Lucintel forecasts that open angle glaucoma is expected to witness highest growth over the forecast period due to rising prevalence of age-related eye conditions such sleep apnea, vascular diseases, and blurred vision.

Asia Pacific is expected to witness highest growth over the forecast period due to advancements in the diagnosis, treatment, and administration of new medications

Features of the Global Glaucoma Market

Market Size Estimates: Glaucoma market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Glaucoma market size by disease type, drug class, distribution channel, and region in terms of value ($B).

Regional Analysis: Glaucoma market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different disease type , drug class , distribution channel , and regions for the glaucoma market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the glaucoma market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q.1 What is the glaucoma market size?

Answer: The global glaucoma market is expected to reach an estimated $12.04 billion by 2030.

Q.2 What is the growth forecast for glaucoma market?

Answer: The global glaucoma market is expected to grow with a CAGR of 7.0% from 2024 to 2030.

Q.3 What are the major drivers influencing the growth of the glaucoma market?

Answer: The major drivers for this market are increasing glaucoma incidence rates and increasing glaucoma awareness and growing need in the field of ophthalmology for novel treatment strategies.

Q4. What are the major segments for glaucoma market?

Answer: The future of the glaucoma market looks promising with opportunities in the hospital pharmacy, retail pharmacy, and online pharmacy markets.

Q5. Who are the key glaucoma market companies?

Answer: Some of the key glaucoma companies are as follows.

  • Pfizer
  • Santen Pharmaceutical
  • Novartis
  • Alcon
  • Akron Operating Company
  • Thea Pharma
  • AbbVie
  • Bausch + Lomb Corporation
  • Teva Pharmaceuticals Industries
  • 0

Q6. Which glaucoma market segment will be the largest in future?

Answer: Lucintel forecasts that open angle glaucoma is expected to witness highest growth over the forecast period due to rising prevalence of age-related eye conditions such sleep apnea, vascular diseases, and blurred vision.

Q7. In glaucoma market, which region is expected to be the largest in next 5 years?

Answer: Asia Pacific is expected to witness highest growth over the forecast period due to advancements in the diagnosis, treatment, and administration of new medications.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the glaucoma market by disease type (open angle glaucoma, angle closure glaucoma, and others), drug class (prostaglandins analogs, beta-blockers, adrenergic agonists, carbonic anhydrase inhibitors, and others), distribution channel (hospital pharmacy, retail pharmacy, and online pharmacy), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Glaucoma Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Glaucoma Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Glaucoma Market by Disease Type
    • 3.3.1: Open Angle Glaucoma
    • 3.3.2: Angle Closure Glaucoma
    • 3.3.3: Others
  • 3.4: Global Glaucoma Market by Drug Class
    • 3.4.1: Prostaglandins Analogs
    • 3.4.2: Beta-blockers
    • 3.4.3: Adrenergic Agonists
    • 3.4.4: Carbonic Anhydrase Inhibitors
    • 3.4.5: Others
  • 3.5: Global Glaucoma Market by Distribution Channel
    • 3.5.1: Hospital Pharmacy
    • 3.5.2: Retail Pharmacy
    • 3.5.3: Online Pharmacy

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Glaucoma Market by Region
  • 4.2: North American Glaucoma Market
    • 4.2.2: North American Glaucoma Market by Distribution Channel: Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy
  • 4.3: European Glaucoma Market
    • 4.3.1: European Glaucoma Market by Disease Type: Open Angle Glaucoma, Angle Closure Glaucoma, and Others
    • 4.3.2: European Glaucoma Market by Distribution Channe: Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy
  • 4.4: APAC Glaucoma Market
    • 4.4.1: APAC Glaucoma Market by Disease Type: Open Angle Glaucoma, Angle Closure Glaucoma, and Others
    • 4.4.2: APAC Glaucoma Market by Distribution Channe: Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy
  • 4.5: ROW Glaucoma Market
    • 4.5.1: ROW Glaucoma Market by Disease Type : Open Angle Glaucoma, Angle Closure Glaucoma, and Others
    • 4.5.2: ROW Glaucoma Market by Distribution Channel: Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Glaucoma Market by Disease Type
    • 6.1.2: Growth Opportunities for the Global Glaucoma Market by Drug Class
    • 6.1.3: Growth Opportunities for the Global Glaucoma Market by Distribution Channel
    • 6.1.4: Growth Opportunities for the Global Glaucoma Market by Region
  • 6.2: Emerging Trends in the Global Glaucoma Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Glaucoma Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Glaucoma Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: Pfizer
  • 7.2: Santen Pharmaceutical
  • 7.3: Novartis
  • 7.4: Alcon
  • 7.5: Akron Operating Company
  • 7.6: Thea Pharma
  • 7.7: AbbVie
  • 7.8: Bausch + Lomb Corporation
  • 7.9: Teva Pharmaceuticals Industries